ANDREA REED: Open Payments
NPI 1639719339 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 21 payments from 10 companies in 2025. Trend: 2023 $474 · 2024 $523 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $98 |
| Phathom Pharmaceuticals, Inc. | 6 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Ipsen Biopharmaceuticals, Inc | 1 | $47 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: VRAYLAR, VOQUEZNA, IQIRVO, AIRSUPRA, TRELEGY ELLIPTA, Ozempic, Heplisav-B, XIFAXAN.
Industry payments across TN — which companies pay providers there.
